Primary Site >> Colorectal Cancer
Gene >> NELFCD
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Ref: Gradual loss of T-helper 1 populations in spleen of mice during progressive tumor growth. PMID: 7674335 Ref: Superantigen-induced human CD4+ helper/killer T cell phenomenon. Selective induction of Th1 helper/killer T cells and application to tumor immunotherapy. PMID: 7836762 |
Ref: Disregulation in TH1 and TH2 subsets of CD4+ T cells in peripheral blood of colorectal cancer patients and involvement in cancer establishment and progression. PMID: 8625361 Ref: Enterocolitis and colon cancer in interleukin-10-deficient mice are associated with aberrant cytokine production and CD4(+) TH1-like responses. PMID: 8770874 Ref: Immunotherapy of experimental metastases by vaccination with interleukin gene-transduced adenocarcinoma cells sharing tumor-associated antigens. Comparison between IL-12 and IL-2 gene-transduced tumor cell vaccines. PMID: 8955204 Ref: Release of cytokines by a fermented lectin-1 (ML-1) free mistletoe extract reflects differences in the reactivity of PBMC in healthy and allergic individuals and tumour patients. PMID: 9010693 Ref: [A retrospective view of tumor immunology]. PMID: 9224970 Ref: Necessity of biotherapeutic treatments inducing TH1 cell functions in colorectal cancer. PMID: 10851498 |
Ref: Cytotoxic T-cell clone against rectal carcinoma induced by stimulation of a patient's peripheral blood mononuclear cells with autologous cultured tumor cells. PMID: 9139862 Ref: Human colorectal cancer (CRC) antigen CO17-1A/GA733 encoded by adenovirus inhibits growth of established CRC cells in mice. PMID: 9218593 Ref: The sCEA molecule suppressive role in NK and TH1 cell functions in colorectal cancer. PMID: 10851473 Ref: IL-10 and sIL-2R serum levels as possible peripheral blood prognostic markers in the passage from adenoma to colorectal cancer. PMID: 10851474 Ref: The role of the soluble CD30 serum level in colorectal cancer: a possible marker for a patient subset which could benefit from IL-2 biotherapy. PMID: 10851480 Ref: Immunological implications of alterations in the c-Ki-ras and p53 genes in the stepwise progression of colorectal cancer: indications for the improvement of prognosis, biotherapy treatment and tumor biology understanding PMID: 10851492 |
Ref: The significance of an increase in soluble interleukin-2 receptor level in colorectal cancer and its biological regulating role in the physiological switching of the immune response cytokine network from TH1 to TH2 and back. PMID: 9439647 Ref: Molecular mimicry of carcinoembryonic antigen by peptides derived from the structure of an anti-idiotype antibody. PMID: 9515808 Ref: Anti-metastatic and immunomodulating properties of the water extract from Celosia argentea seeds. PMID: 9853404 |
Ref: Role of NK and T cells in IL-12-induced anti-tumor response against hepatic colon carcinoma. PMID: 10328238 Ref: Modulation of interleukin-18 expression in human colon carcinoma: consequences for tumor immune surveillance. PMID: 10371355 Ref: T cell memory against colon carcinoma is long-lived in the absence of antigen. PMID: 10490962 Ref: IL-10 expression by CT26 colon carcinoma cells inhibits their malignant phenotype and induces a T cell-mediated tumor rejection in the context of a systemic Th2 response. PMID: 10516719 |
Ref: Mice vaccination with interleukin 12-transduced colon cancer cells potentiates rejection of syngeneic non-organ-related tumor cells. PMID: 11118055 |
Ref: Minimal costimulatory requirements for T cell priming and TH1 differentiation: activation of naive human T lymphocytes by tumor cells armed with bifunctional antibody constructs. PMID: 12747771 |
Ref: Secretion of interleukin-10 from murine colon carcinoma cells suppresses systemic antitumor immunity and impairs protective immunity induced against the tumors. PMID: 11916240 Ref: Characterization of structures with T-lymphocyte aggregates in ileal villi of Crohn's disease. PMID: 12135029 Ref: Efficacy of intraperitoneal thermochemotherapy and immunotherapy in intraperitoneal recurrence after gastrointestinal cancer resection. PMID: 12439917 |
Ref: Murine dendritic cells pulsed with an anti-idiotype antibody induce antigen-specific protective antitumor immunity. PMID: 12782590 Ref: Intensification of antitumor effect by T helper 1-dominant adoptive immunogene therapy for advanced orthotopic colon cancer. PMID: 12796406 Ref: Passage from normal mucosa to adenoma and colon cancer: alteration of normal sCD30 mechanisms regulating TH1/TH2 cell functions. PMID: 14503949 Ref: Magnitude and polarization of P53-specific T-helper immunity in connection to leukocyte infiltration of colorectal tumors. PMID: 14506743 Ref: Antitumor effects of interleukin-18 gene-modified hepatocyte cell line on implanted liver carcinoma. PMID: 14570604 Ref: Locoregional immunotherapy of malignant effusion from colorectal cancer using the streptococcal preparation OK-432 plus interleukin-2: induction of autologous tumor-reactive CD4+ Th1 killer lymphocytes. PMID: 14612896 Ref: Overexpression of leptin mRNA in mesenteric adipose tissue in inflammatory bowel diseases. PMID: 14732844 |
Ref: Immunopharmacological and antitumor effects of second-generation immunomodulatory oligonucleotides containing synthetic CpR motifs. PMID: 15010828 Ref: [Dendritomas plays an important role in the activation of anti-tumor immune responses]. PMID: 15200907 Ref: Expression of CXCL16 in human rectal cancer. PMID: 15202017 Ref: Dendritic cells pulsed with an anti-idiotype antibody mimicking carcinoembryonic antigen (CEA) can reverse immunological tolerance to CEA and induce antitumor immunity in CEA transgenic mice. PMID: 15256474 Ref: Vaccination with Ep-CAM protein or anti-idiotypic antibody induces Th1-biased response against MHC class I- and II-restricted Ep-CAM epitopes in colorectal carcinoma patients. PMID: 15328177 Ref: Thymalfasin: an immune system enhancer for the treatment of liver disease. PMID: 15546253 Ref: [The repetitive immune cell transfer therapy combining non-myelosuppressive chemotherapy for patients with advanced and refractory cancer]. PMID: 15553672 Ref: [Host immunity in colorectal cancer patients treated with low-dose Leucovorin plus 5-fluorouracil]. PMID: 15553714 Ref: Expression of chemokine receptor CXCR6 in human colorectal adenocarcinomas. PMID: 15736401 |
Ref: Exogenous histamine stimulates colorectal cancer implant growth via immunosuppression in mice. PMID: 15655289 Ref: Interleukin-4 gene transduced tumor cells promote a potent tumor-specific Th1-type response in cooperation with interferon-alpha transduction. PMID: 15772692 Ref: Effects of PSK on T and dendritic cells differentiation in gastric or colorectal cancer patients. PMID: 15816609 Ref: Selective infiltration of CCR5(+)CXCR3(+) T lymphocytes in human colorectal carcinoma. PMID: 15856455 Ref: Increased rejection of primary tumors in mice lacking B cells: inhibition of anti-tumor CTL and TH1 cytokine responses by B cells. PMID: 15912532 Ref: Hsp70-like protein 1 fusion protein enhances induction of carcinoembryonic antigen-specific CD8+ CTL response by dendritic cell vaccine. PMID: 15930317 Ref: Cytokine expression in colon carcinoma. PMID: 16158955 Ref: [Host immunity in colorectal cancer patients treated with TS-1 plus CPT-11]. PMID: 16315879 Ref: Distinct immune response induced by peptidoglycan derived from Lactobacillus sp. PMID: 16419162 |
Ref: CpG oligonucleotides enhance the tumor antigen-specific immune response of an anti-idiotype antibody-based vaccine strategy in CEA transgenic mice. PMID: 16044253 Ref: Predominant T helper type 2-inflammatory responses promote murine colon cancers. PMID: 16331625 Ref: Aberrant T helper cell response in tumor-bearing mice limits the efficacy of dendritic cell vaccine. PMID: 16388858 Ref: Preoperative oral immune-enhancing nutritional supplementation corrects TH1/TH2 imbalance in patients undergoing elective surgery for colorectal cancer. PMID: 16421661 Ref: Antitumor activity and immune enhancement of murine interleukin-23 expressed in murine colon carcinoma cells. PMID: 16549049 Ref: Antiangiogenic and antitumor activities of IL-27. PMID: 16751375 Ref: Antitumor activity of chimeric immunoreceptor gene-modified Tc1 and Th1 cells against autologous carcinoembryonic antigen-expressing colon cancer cells. PMID: 16856879 Ref: Peptidome from renal cell carcinoma contains antigens recognized by CD4+ T cells and shared among tumors of different histology. PMID: 16914584 Ref: Dendritic cell-tumor cell hybrids enhance the induction of cytotoxic T lymphocytes against murine colon cancer: a comparative analysis of antigen loading methods for the vaccination of immunotherapeutic dendritic cells. PMID: 17089056 Ref: Are immunological mechanisms involved in colon cancer and are they possible markers for biotherapy improvement? PMID: 17105420 |
Ref: Superior anti-tumor protection and therapeutic efficacy of vaccination with allogeneic and semiallogeneic dendritic cell/tumor cell fusion hybrids for murine colon adenocarcinoma. PMID: 17131118 Ref: Reduced expression of microenvironmental Th1 cytokines accompanies adenomas-carcinomas sequence of colorectum. PMID: 17160410 Ref: Immunomodulatory effects of (n-3) fatty acids: putative link to inflammation and colon cancer. PMID: 17182826 Ref: Does impaired TH1/TH2 balance cause postoperative infectious complications in colorectal cancer surgery? PMID: 17292403 Ref: Therapy of established tumors in a novel murine model transgenic for human carcinoembryonic antigen and HLA-A2 with a combination of anti-idiotype vaccine and CTL peptides of carcinoembryonic antigen. PMID: 17363612 Ref: Distinct changes of dendritic cell number and IL-12 mRNA level in adjacent mucosa throughout the colorectal adenoma-carcinoma sequence. PMID: 17579859 Ref: Rofecoxib has different effects on chemokine production in colorectal cancer cells and tumor immune splenocytes. PMID: 17667525 Ref: Characterization of antigen-specific immune responses induced by canarypox virus vaccines. PMID: 17947686 Ref: Colorectal resection by a minilaparotomy approach vs. conventional operation for colon cancer. Results of a prospective randomized trial. PMID: 18251141 |
Ref: Enhancement of anti-tumor activity in vitro and in vivo by CD150 and SAP. PMID: 17692919 Ref: Dysregulation in immune functions is reflected in tumor cell cytotoxicity by peripheral blood mononuclear cells from head and neck squamous cell carcinoma patients. PMID: 18547033 Ref: Intestinal deletion of Pofut1 in the mouse inactivates notch signaling and causes enterocolitis. PMID: 18621050 Ref: CpG methylation of the IFNG gene as a mechanism to induce immunosuppression [correction of immunosupression] in tumor-infiltrating lymphocytes. PMID: 18684979 Ref: Polarization of cytokine profile from Th1 into Th2 along colorectal adenoma-carcinoma sequence: implications for the biotherapeutic target? PMID: 18691138 Ref: Optimal amount of monocyte chemoattractant protein-1 enhances antitumor effects of suicide gene therapy against hepatocellular carcinoma by M1 macrophage activation. PMID: 19016769 |
Ref: Impact of surgery on immunologic function: comparison between minimally invasive techniques and conventional laparotomy for surgical resection of colorectal tumors. PMID: 18639228 Ref: Multiple putative oncogenes at the chromosome 20q amplicon contribute to colorectal adenoma to carcinoma progression. PMID: 18829976 Ref: Intratumoral interferon-alpha gene transfer enhances tumor immunity after allogeneic hematopoietic stem cell transplantation. PMID: 18998126 Ref: Identification of CD8+CD25+Foxp3+ suppressive T cells in colorectal cancer tissue. PMID: 19022917 Ref: Stimulatory effects of CpG oligodeoxynucleotide on dendritic cell-based immunotherapy of colon cancer in CEA/HLA-A2 transgenic mice. PMID: 19035460 Ref: Modulators of arginine metabolism support cancer immunosurveillance. PMID: 19134173 Ref: EpCAM, a human tumor-associated antigen promotes Th2 development and tumor immune evasion. PMID: 19188665 Ref: Coordination of intratumoral immune reaction and human colorectal cancer recurrence. PMID: 19258510 Ref: Enrichment of human CD4+ V(alpha)24/Vbeta11 invariant NKT cells in intrahepatic malignant tumors. PMID: 19342695 Ref: Changes in cytokine and biomarker blood levels in patients with colorectal cancer during dendritic cell-based vaccination. PMID: 19863224 |
Ref: The effect of colorectal cancer upon host peripheral immune cell function. PMID: 19250260 Ref: Pilot study of sentinel-node-based adoptive immunotherapy in advanced colorectal cancer. PMID: 20119674 Ref: PSK may suppress CD57(+) T cells to improve survival of advanced gastric cancer patients. PMID: 20229169 Ref: A polysaccharide extracted from Grifola frondosa enhances the anti-tumor activity of bone marrow-derived dendritic cell-based immunotherapy against murine colon cancer. PMID: 20563803 Ref: Netrin-1 regulates Th1/Th2/Th17 cytokine production and inflammation through UNC5B receptor and protects kidney against ischemia-reperfusion injury. PMID: 20693423 Ref: Anticancer properties of the IL-12 family--focus on colorectal cancer. PMID: 20712574 Ref: Dendritic cell vaccination of patients with metastatic colorectal cancer. PMID: 20816019 Ref: Ligand-independent toll-like receptor signals generated by ectopic overexpression of MyD88 generate local and systemic antitumor immunity. PMID: 20823152 Ref: [Influence of FOLFOX regimen on the immunologic function in patients with advanced colorectal cancer]. PMID: 20878571 Ref: Dendritic cell vaccine in addition to FOLFIRI regimen improve antitumor effects through the inhibition of immunosuppressive cells in murine colorectal cancer model. PMID: 20883737 Ref: [Immunoregulatory effects of PSK on the Th1/Th2 balance and regulatory T-cells in patients with colorectal cancer]. PMID: 21224532 Ref: Induction of 90K-specific Cytotoxic T Lymphocytes for Colon Cancer Immunotherapy. PMID: 21286381 |
Ref: Immune infiltration in human cancer: prognostic significance and disease control. PMID: 20512556 Ref: Suppression of intestinal inflammation and inflammation-driven colon cancer in mice by dietary sphingomyelin: importance of peroxisome proliferator-activated receptor gamma expression. PMID: 21295961 Ref: Clinical impact of different classes of infiltrating T cytotoxic and helper cells (Th1, th2, treg, th17) in patients with colorectal cancer. PMID: 21303976 Ref: Inflammation: a role for NR4A orphan nuclear receptors? PMID: 21428963 Ref: A novel combined conjugate vaccine: enhanced immunogenicity of bFGF with CRM197 as a carrier protein. PMID: 21720718 Ref: Environmental and lifestyle influences on disorders of the large and small intestine: implications for treatment. PMID: 21734392 Ref: [Vaccine therapies against digestive-system cancers]. PMID: 21922771 |
Ref: CpG ODN, Toll like receptor (TLR)-9 agonist, inhibits metastatic colon adenocarcinoma in a murine hepatic tumor model. PMID: 21324492 Ref: Chronic psychosocial stress increases the risk for inflammation-related colon carcinogenesis in male mice. PMID: 22044139 Ref: Stat6 activity-related Th2 cytokine profile and tumor growth advantage of human colorectal cancer cells in vitro and in vivo. PMID: 22108090 Ref: Biological mechanism and clinical effect of protein-bound polysaccharide K (KRESTIN((R))): review of development and future perspectives. PMID: 22139128 Ref: First clinical trial of cancer vaccine therapy with artificially synthesized helper/ killer-hybrid epitope long peptide of MAGE-A4 cancer antigen. PMID: 22221328 Ref: Accumulation of CCR4(+)CTLA-4 FOXP3(+)CD25(hi) regulatory T cells in colon adenocarcinomas correlate to reduced activation of conventional T cells. PMID: 22319577 Ref: Interleukin-4 and CpG oligonucleotide therapy suppresses the outgrowth of tumors by activating tumor-specific Th1-type immune responses. PMID: 22426807 Ref: Effects of interferon-alpha-transduced tumor cell vaccines and blockade of programmed cell death-1 on the growth of established tumors. PMID: 22790963 Ref: Reprogramming the immune system in IBD. PMID: 22796803 Ref: Role of nuclear receptor NR4A2 in gastrointestinal inflammation and cancers. PMID: 23322982 |
Ref: GBP-1 acts as a tumor suppressor in colorectal cancer cells. PMID: 23042300 Ref: Integrated analysis of genome-wide copy number alterations and gene expression in microsatellite stable, CpG island methylator phenotype-negative colon cancer. PMID: 23341073 Ref: Shedding LIGHT (TNFSF14) on the tumor microenvironment of colorectal cancer liver metastases. PMID: 23514280 Ref: Dendritic cell-based immunotherapy for colon cancer using an HLA-A*0201-restricted cytotoxic T-lymphocyte epitope from tumor-associated antigen 90K. PMID: 23524651 Ref: Characteristics and clinical impacts of the immune environments in colorectal and renal cell carcinoma lung metastases: influence of tumor origin. PMID: 23785047 Ref: Opposing Functions of Classic and Novel IL-1 Family Members in Gut Health and Disease. PMID: 23847622 Ref: A novel chronic stress-induced shift in the Th1 to Th2 response promotes colon cancer growth. PMID: 24036270 Ref: IL-18-based combinatorial adjuvants promote the intranodal production of CCL19 by NK cells and dendritic cells of cancer patients. PMID: 24228233 Ref: B cell regulation of anti-tumor immune response. PMID: 24293009 Ref: Escalating regulation of 5T4-specific IFN-gamma(+) CD4(+) T cells distinguishes colorectal cancer patients from healthy controls and provides a target for in vivo therapy. PMID: 24409450 |
Ref: TLR4 is essential for dendritic cell activation and anti-tumor T-cell response enhancement by DAMPs released from chemically stressed cancer cells. PMID: 24362470 Ref: Master regulator of intestinal disease: IL-6 in chronic inflammation and cancer development. PMID: 24447345 Ref: Transient ablation of regulatory T cells improves antitumor immunity in colitis-associated colon cancer. PMID: 24906621 Ref: Circulating follicular helper T cells in Crohn's disease (CD) and CD-associated colorectal cancer. PMID: 24943684 Ref: Immune response to JC virus T antigen in patients with and without colorectal neoplasia. PMID: 25007286 Ref: The effect of immune microenvironment on the progression and prognosis of colorectal cancer. PMID: 25034363 Ref: Characterization of an adaptive immune response in microsatellite-instable colorectal cancer. PMID: 25101223 Ref: Heteroclitic XBP1 peptides evoke tumor-specific memory cytotoxic T lymphocytes against breast cancer, colon cancer, and pancreatic cancer cells. PMID: 25941601 |
Ref: The vigorous immune microenvironment of microsatellite instable colon cancer is balanced by multiple counter-inhibitory checkpoints. PMID: 25358689 Ref: Temporary elimination of IL-10 enhanced the effectiveness of cyclophosphamide and BMDC-based therapy by decrease of the suppressor activity of MDSCs and activation of antitumour immune response. PMID: 25454807 Ref: Cytokine networks in animal models of colitis-associated cancer. PMID: 25550530 Ref: The microsatellite instable subset of colorectal cancer is a particularly good candidate for checkpoint blockade immunotherapy. PMID: 25583798 Ref: Strengthened tumor antigen immune recognition by inclusion of a recombinant Eimeria antigen in therapeutic cancer vaccination. PMID: 25655760 Ref: Assessing the prognostic value of preoperative carcinoembryonic antigen-specific T-cell responses in colorectal cancer. PMID: 25669203 Ref: Therapeutic antitumor immunity by checkpoint blockade is enhanced by ibrutinib, an inhibitor of both BTK and ITK. PMID: 25730880 Ref: Immune signature of tumor infiltrating immune cells in renal cancer. PMID: 25949868 Ref: Anti-tumour immune effect of oral administration of Lactobacillus plantarum to CT26 tumour-bearing mice. PMID: 25963256 Ref: X-shaped DNA potentiates therapeutic efficacy in colitis-associated colon cancer through dual activation of TLR9 and inflammasomes. PMID: 25971982 Ref: Immunomodelling Characteristics of Mature Dendritic Cells Stimulated by Colon Cancer Cells Lysates. PMID: 26146098 Ref: Immune checkpoint blockade in microsatellite instable colorectal cancers: Back to the clinic. PMID: 26155426 Ref: Dendritic cell vaccination with a toll-like receptor agonist derived from mycobacteria enhances anti-tumor immunity. PMID: 26418952 Ref: Mismatch repair gene defects in sporadic colorectal cancer enhance immune surveillance. PMID: 26496037 Ref: Increased tumor infiltration by mucosal-associated invariant T cells correlates with poor survival in colorectal cancer patients. PMID: 26497850 |
Ref: Co-operation of alpha-galactosylceramide-loaded tumour cells and TLR9 agonists induce potent anti-tumour responses in a murine colon cancer model. PMID: 26450924 Ref: A High RORgammaT/CD3 Ratio is a Strong Prognostic Factor for Postoperative Survival in Advanced Colorectal Cancer: Analysis of Helper T Cell Lymphocytes (Th1, Th2, Th17 and Regulatory T Cells). PMID: 26564244 Ref: PRC2 Epigenetically Silences Th1-Type Chemokines to Suppress Effector T-Cell Trafficking in Colon Cancer. PMID: 26567139 Ref: Protein disulfide isomerase A3-specific Th1 effector cells infiltrate colon cancer tissue of patients with circulating anti-protein disulfide isomerase A3 autoantibodies. PMID: 26772958 Ref: Modulation of chemokines in the tumor microenvironment enhances oncolytic virotherapy for colorectal cancer. PMID: 26956047 Ref: Integrative Analyses of Colorectal Cancer Show Immunoscore Is a Stronger Predictor of Patient Survival Than Microsatellite Instability. PMID: 26982367 Ref: Induction of immunogenic cell death by radiation-upregulated karyopherin alpha 2 in vitro. PMID: 27107455 Ref: Interleukin (IL)-24 transforms the tumor microenvironment and induces anticancer immunity in a murine model of colon cancer. PMID: 27209087 Ref: Helicobacter saguini, a Novel Helicobacter Isolated from Cotton-Top Tamarins with Ulcerative Colitis, Has Proinflammatory Properties and Induces Typhlocolitis and Dysplasia in Gnotobiotic IL-10-/- Mice. PMID: 27245408 Ref: Immunoprevalence and magnitude of HLA-DP4 versus HLA-DR-restricted spontaneous CD4(+) Th1 responses against telomerase in cancer patients. PMID: 27467955 Ref: The infiltration, and prognostic importance, of Th1 lymphocytes vary in molecular subgroups of colorectal cancer. PMID: 27499912 Ref: Pathophysiological role of guanylate-binding proteins in gastrointestinal diseases. PMID: 27605879 Ref: Differential effects of peptidoglycan on colorectal tumors and intestinal tissue post-pelvic radiotherapy. PMID: 27708223 Ref: Host-Protozoan Interactions Protect from Mucosal Infections through Activation of the Inflammasome. PMID: 27716507 Ref: Matricellular protein SPARCL1 regulates tumor microenvironment-dependent endothelial cell heterogeneity in colorectal carcinoma. PMID: 27721236 Ref: Analysis of histological and immunological parameters of metastatic lymph nodes from colon cancer patients reveals that T-helper 1 type immune response is associated with improved overall survival. PMID: 27828856 Ref: Soluble IL-33 receptor sST2 inhibits colorectal cancer malignant growth by modifying the tumour microenvironment. PMID: 27882929 Ref: The Agaricus blazei-Based Mushroom Extract, Andosan, Protects against Intestinal Tumorigenesis in the A/J Min/+ Mouse. PMID: 28002446 Ref: Increased transforming growth factor beta and interleukin 10 transcripts in peripheral blood mononuclear cells of colorectal cancer patients. PMID: 28239283 Ref: Peritoneal carcinomatosis of colorectal cancer is characterized by structural and functional reorganization of the tumor microenvironment inducing senescence and proliferation arrest in cancer cells. PMID: 28439450 Ref: A novel cancer vaccine with the ability to simultaneously produce anti-PD-1 antibody and GM-CSF in cancer cells and enhance Th1-biased antitumor immunity. PMID: 29263903 |
Ref: Hemidesmosome integrity protects the colon against colitis and colorectal cancer. PMID: 27371534 Ref: A model for lymphocyte activation in open versus laparoscopic surgery in colorectal cancer patients in enhanced recovery after surgery (ERAS) protocols. PMID: 27900463 Ref: T lymphocyte SHP2-deficiency triggers anti-tumor immunity to inhibit colitis-associated cancer in mice. PMID: 27935860 Ref: Food-grade TiO2 impairs intestinal and systemic immune homeostasis, initiates preneoplastic lesions and promotes aberrant crypt development in the rat colon. PMID: 28106049 Ref: [Focus on the Immunoscore and its potential clinical implications]. PMID: 28161000 Ref: Defective IL-23/IL-17 Axis Protects p47phox-/- Mice from Colon Cancer. PMID: 28191009 Ref: Deficiency of the immunostimulatory cytokine IL-21 promotes intestinal neoplasia via dysregulation of the Th1/Th17 axis. PMID: 28197386 Ref: Combination therapy with dendritic cells and lenalidomide is an effective approach to enhance antitumor immunity in a mouse colon cancer model. PMID: 28460478 Ref: Curcumin up regulates T helper 1 cells in patients with colon cancer. PMID: 28469791 Ref: T cell immunity induced by a bivalent Salmonella-based CEACAM6 and 4-1BBL vaccines in a rat colorectal cancer model. PMID: 28521477 Ref: Tumor growth limited to subcutaneous site vs tumor growth in pulmonary site exhibit differential effects on systemic immunities. PMID: 28535011 Ref: A cancer vaccine based on fluorine-modified sialyl-Tn induces robust immune responses in a murine model. PMID: 28537884 Ref: CD103+ Dendritic Cell Function Is Altered in the Colons of Patients with Ulcerative Colitis. PMID: 28700533 Ref: Bifidobacterium Infantis Ameliorates Chemotherapy-Induced Intestinal Mucositis Via Regulating T Cell Immunity in Colorectal Cancer Rats. PMID: 28848081 Ref: Inhibition and deficiency of the immunoproteasome subunit LMP7 suppress the development and progression of colorectal carcinoma in mice. PMID: 28881611 Ref: Upregulation of bacterial-specific Th1 and Th17 responses that are enriched in CXCR5(+)CD4(+) T cells in non-small cell lung cancer. PMID: 28982050 |
Ref: HSP70L1-mediated intracellular priming of dendritic cell vaccination induces more potent CTL response against cancer. PMID: 27345726 Ref: Unique invariant natural killer T cells promote intestinal polyps by suppressing TH1 immunity and promoting regulatory T cells. PMID: 28401935 Ref: The Balance Between Cytotoxic T-cell Lymphocytes and Immune Checkpoint Expression in the Prognosis of Colon Tumors. PMID: 28922790 Ref: KRAS Mutation and Consensus Molecular Subtypes 2 and 3 Are Independently Associated with Reduced Immune Infiltration and Reactivity in Colorectal Cancer. PMID: 29061646 Ref: Vaccination with human amniotic epithelial cells confer effective protection in a murine model of Colon adenocarcinoma. PMID: 29139122 Ref: Comparative analysis of immune function, hemorheological alterations and prognosis in colorectal cancer patients with different traditional Chinese medicine syndromes. PMID: 29171989 Ref: Phase I clinical trial of adoptive transfer of expanded natural killer cells in combination with IgG1 antibody in patients with gastric or colorectal cancer. PMID: 29388200 Ref: Gut microbiota modulate T cell trafficking into human colorectal cancer. PMID: 29437871 Ref: TGFbeta drives immune evasion in genetically reconstituted colon cancer metastasis. PMID: 29443964 Ref: Distinctive profiles of tumor-infiltrating immune cells and association with intensity of infiltration in colorectal cancer. PMID: 29456737 Ref: Protumor Steering of Cancer Inflammation by p50 NF-kappaB Enhances Colorectal Cancer Progression. PMID: 29588321 Ref: Isolation of Human Endothelial Cells from Normal Colon and Colorectal Carcinoma - An Improved Protocol. PMID: 29683458 Ref: Differential role of CXCR3 in inflammation and colorectal cancer. PMID: 29707158 Ref: Analysis of Th22, Th17 and CD4(+)cells co-producing IL-17/IL-22 at different stages of human colon cancer. PMID: 29710675 Ref: Subsite heterogeneity in the profiles of circulating cytokines in colorectal cancer. PMID: 29801973 Ref: Pharmacologic inhibition of protein phosphatase-2A achieves durable immune-mediated antitumor activity when combined with PD-1 blockade. PMID: 29844427 Ref: Diagnostic value of peripheral blood immune profiling in colorectal cancer. PMID: 29854709 Ref: Reprogramming the murine colon cancer microenvironment using lentivectors encoding shRNA against IL-10 as a component of a potent DC-based chemoimmunotherapy. PMID: 29954431 Ref: Modified Fe3O4 Magnetic Nanoparticle Delivery of CpG Inhibits Tumor Growth and Spontaneous Pulmonary Metastases to Enhance Immunotherapy. PMID: 30120629 Ref: Large-Pore Mesoporous-Silica-Coated Upconversion Nanoparticles as Multifunctional Immunoadjuvants with Ultrahigh Photosensitizer and Antigen Loading Efficiency for Improved Cancer Photodynamic Immunotherapy. PMID: 30387197 |